阅读说明：本技术 有机化合物 (Organic compounds ) 是由 李鹏 张强 R·戴维斯 于 2019-12-17 设计创作，主要内容包括：本发明涉及游离形式、或可药用盐形式、和/或如本文所述的基本上纯形式的特定取代的杂环稠合的γ-咔啉、其药物组合物、及用于治疗涉及5-HT-(2A)受体、血清素转运蛋白(SERT)和/或涉及多巴胺D1和D2受体信号传导系统的途径的疾病的方法。(The present invention relates to certain substituted heterocycle fused gamma-carbolines in free form, or in pharmaceutically acceptable salt form, and/or in substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use thereof for treating conditions involving 5-HT 2A A receptor, a serotonin transporter (SERT) and/or a disease involving pathways of the dopamine D1 and D2 receptor signaling systems.)